|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Deferred income tax expense | |||||
| Depreciation and amortization | |||||
| Share-based compensation | |||||
| Interest related to contract termination liability payment | |||||
| Earnings of equity method investment in related party | |||||
| Impairment of investments | |||||
| Transaction termination costs - Kakaopay fee | |||||
| Changes in | |||||
| Securities segregated for regulatory purposes | |||||
| Receivables from customers | |||||
| Receivables from non-customers | |||||
| Receivables from and deposits with broker-dealers and clearing organizations | |||||
| Securities borrowed | |||||
| Securities owned, at fair value | |||||
| Prepaid expenses and other assets | |||||
| Payables to customers | |||||
| Payables to non-customers | |||||
| Drafts payable | |||||
| Payables to broker-dealers and clearing organizations | |||||
| Accounts payable and accrued liabilities | |||||
| Securities loaned | |||||
| Securities sold, not yet purchased, at fair value | |||||
| Net lease liabilities | |||||
| Earnings of equity method investment in related parties | |||||
| Taxes payable / receivable | |||||
| Deferred contract incentive | |||||
| Retail Trading Platform implementation | |||||
| Contract termination payment | |||||
| Technology platform integration | |||||
| Other deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Purchase of office facilities and equipment | |||||
| Build out of property | |||||
| Purchase of software | |||||
| Additions to property, office facilities, and equipment | |||||
| Acquisition of BMLG assets | |||||
| Investment in FusionIQ | |||||
| Media production cost | |||||
| Transaction with J2 Financial | |||||
| Cash paid in a business acquisition, net of cash and cash equivalents acquired | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Kakaopay issuance cost | |||||
| Shares issued for Kakaopay transaction | |||||
| Bank loan - short term | |||||
| RISE cash distribution | |||||
| RISE share repurchase | |||||
| Repayments of long-term debt | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash and cash equivalents, and cash segregated for regulatory purposes | |||||
| Cash and cash equivalents, and cash segregated for regulatory purposes - beginning of year | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | |||||
| Cash and cash equivalents, and cash segregated for regulatory purposes - end of year | |||||
| Supplemental cash flow information | |||||
| Cash paid during the year for income taxes | |||||
| Cash paid, net of refunds received during the year for income taxes | |||||
| Cash paid during the year for interest | |||||
| Non-cash investing and financing activities | |||||
| Equity method investment in related party | |||||
| Kakaopay issuance cost | |||||
| Transaction with J2 Financial | |||||
| Share-based compensation | |||||
| Treasury stock | |||||
| Non-cash consideration due to Kakaopay transaction | |||||
| RISE share repurchase - payable portion | |||||
| RISE tax impact | |||||
| Reconciliation of cash, cash equivalents, and cash and securities segregated for regulatory purposes | |||||
| Cash and cash equivalents - end of year | |||||
| Cash segregated for regulatory purposes - end of year | |||||
Loading...